You can't help but think reclassification of marijuana is

New Post Public Reply Private Reply Replies (1) Message Board
Health1 MattySimone #2016
You can't help but think reclassification of marijuana is around the corner! Could this be the beginning of a run:

Federal Reclassification of Marijuana Could Have Major Impact on Medical Uses
By GILLIAN MOHNEY Apr 11, 2016, 1:23 PM ET


Federal authorities have announced that they are reviewing the possibility of loosening the classification of marijuana, and if this happens, it could have a far-reaching impact on how the substance is used in medical settings, experts said.

Marijuana is currently classified as a Schedule I drug, meaning it is listed alongside heroin and LSD as among the "most dangerous drugs" and has "no currently accepted medical use and a high potential for abuse."

The Drug Enforcement Agency announced last week that it is reviewing the possibility of reclassifying it as a Schedule II drug, which would put it in the same category as Ritalin, Adderal and oxycodone.

Medical experts are welcoming the review, saying it could ease restrictions for researchers, so that they can better understand which compounds in marijuana could be used to help patients.

The American Medical Association told ABC News that the group supports the review "to help facilitate scientific research and the development of cannabinoid-based medicines."

"The Drug Enforcement Administration should work with other federal regulatory agencies to develop a special schedule for marijuana to facilitate study of its potential medical utility in prescription drug products," AMA officials told ABC News in a statement.

"Current standards for approval of prescription drug products require rigorous scientific study. While studies related to a limited number of medical conditions have shown promise for new cannabinoid-based prescription products, the scope of rigorous research needs to be expanded to a broader range of medical conditions for such products," the AMA added.

Dr. Kevin Hill, assistant professor of psychiatry at McLean Hospital and Harvard Medical School, published a review of medical marijuana in the Journal of the American Medical Association in 2015. In that review, he emphasized there are significant barriers for researchers who want to study marijuana for its medicinal potential.

There are "hoops you have to run through for this research," Hill told ABC News. "If you use marijuana itself, you have to get special licensing from the DEA. It involves a background visit and ... they don’t give it out very easily."

There are currently two marijuana-derived medications approved by the U.S. Food and Drug Administration, Hill noted. The active ingredients in both medications are a group of compounds known as cannabinoids, and these chemicals are approved for nerve pain and for stimulating appetite in patients undergoing cancer treatment, Hill said. However, many other people use medical marijuana or marijuana-derived compounds for a host of other conditions from epilepsy to vertigo, he said.

"We know that medical marijuana has good evidence for treatment for a handful of medical conditions," Hill said. "There are thousands of people who are using medical marijuana for a whole host of medical conditions," where the efficacy has yet to be thoroughly studied.

By changing the classification of the drug, Hill said researchers and doctors could find out how effective marijuana is in other conditions.

"We could move toward a more evidence-based use of medical marijuana," Hill said.

Hill pointed out there are around 60 known compounds in marijuana and that many have not been thoroughly studied by researchers looking for medicinal uses. A new classification will mean it will be easier for researchers to obtain licenses to examine these chemicals for medical treatments and to access suppliers, experts said.

Steph Sherer, the founder of the medical marijuana advocacy group Americans for Safe Access, said changing the classification could be a "paradigm change." She pointed out there is currently only one supplier of medical marijuana for researchers.

"It will allow more federal institutions to engage in research and allow the NIDA [National Institute on Drug Abuse] to open up its source for cannabis so there’s not just one place for researchers to use" marijuana, she explained.

The DEA along with the U.S. Department of Health and Human Services and Office of National Drug Control Policy announced they would review marijuana's classification after multiple letters from senators last year, including Sen. Elizabeth Warren, D-Massachusetts, and Sen. Kirsten Gillibrand, D-New York.

"For too long schedule I status for marijuana has been a barrier for necessary research, and as a result countless Americans can't get access to medicine they desperately need," Gillibrand said in a statement last week. "It's past due for the DEA to reconsider marijuana's status. I am hopeful that antiquated ideology won't continue to stand in the way of science and that the DEA will reschedule marijuana to schedule II."

http://abcnews.go.com/Health/federal-reclassi...d=38308268




Bots Inc. (BTZI) Stock Research Links

BTZI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 92

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 48

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Why Insurance Must Change as Family Assets Keep Growing

Updated Category News Views 73

A policy bought in the starter-home years can turn stale quietly while everything around it gets bigger, pricier and more complicated. That is the uncomfortable little truth behind Daniel C. DiCocco's discussion in HelloNation: families often treat insurance as a box checked long ago, even as they add property, savings, debt, children and fresh responsibilities. Static...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 37

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 58

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 79

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 46

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading

Top 5 Most Recently Viewed Articles

Thompson Thrift Secures Over $255 Million in New Funding

Updated Category News Views 303

Thompson Thrift Closes Major Funding Round for Multifamily Developments Thompson Thrift, a well-known real estate company, recently announced a significant achievement in closing its 2025 multifamily development fund. This limited partnership offering successfully raised over $255 million in capital commitments, exceeding its original target of $230 million. The funds aim...

Continue Reading
Buyglobal's Summer Sale Offers Outdoor Essentials and Deals

Updated Category News Views 25

Buyglobal's Summer Event: A Sunny Boost for Backyard Living Summer's rolling in, and Buyglobal is gearing up to help you transform those backyard spaces into your very own oasis. This ain't your average sale event—this is Buyglobal jumping headfirst into the season with a curated lineup that's all about making the most of the outdoors. They rolled out their...

Continue Reading
Tony Fadell Champions Plumerai's Tiny AI for Smart Homes

Updated Category News Views 201

Transforming Smart Home Security with Tiny AI In the realm of innovative technology, Tony Fadell, co-creator of the iPod and Nest founder, recognizes the groundbreaking work Plumerai is doing in the field of artificial intelligence. Their emphasis on Tiny AI technology is heralded as a pivotal shift that aims to democratize AI for everyday use, particularly in smart home...

Continue Reading
Glenn Pushis Takes Action: Sells $172K in Steel Dynamics Shares

Updated Category News Views 183

Understanding Insider Actions at Steel Dynamics A notable insider transaction has come to light involving Glenn Pushis, the Senior Vice President at Steel Dynamics (NASDAQ: STLD). This transaction was detailed through an SEC filing that disclosed a significant sell-off of shares worth $172,043. Details of the Sell-Transaction According to the Form 4 filing submitted to...

Continue Reading
SCF Partners Strengthens Market Position with New Acquisition

Updated Category News Views 228

SCF Partners' Strategic Acquisition of Newpark Fluids Systems SCF Partners is making waves with its recent acquisition of Newpark Fluids Systems, a well-respected name in the oil, gas, and geothermal fluids industry. This strategic decision underscores SCF's dedication to broadening its service offerings and expanding its market presence. Newpark Fluids Systems has built...

Continue Reading